NEWS

Start Codon, the new healthcare accelerator based in the Milner Therapeutics Institute, today announced the first cohort of four companies who were enrolled in the programme this February and will debut at the Milner Symposium event this Friday June 26th and ONHelix...

We are delighted to announce that Eisai have joined the Milner Therapeutics Consortium, which now includes 8 pharma partners. Eisai is a leading global research and development-based pharmaceutical company headquartered in Japan. Eisai’s corporate mission is defined...

We have been busy adapting plans for the coming months, and are pleased to announce that our Milner seminars are moving online. The first talk is from Mathew Garnett, and we hope you will join us online for this!  Dr Mathew Garnett (Wellcome Sanger Institute)...

Thank you to the numerous Milner affiliated companies who have been in contact to offer support  to the University and NHS at this time. Help tackle COVID-19 through research collaborations, by donating equipment or funding research The University of Cambridge is...

As part of the response to COVID-19 at the University of Cambridge, the Milner Therapeutics Institute will be closed for non-essential business from Friday March 20th until further notice. Events planned for March and April, including the Milner seminar series, have...

We are delighted that Dr Konstantinos Tzelepis has moved into the Milner Centre for Pathway Analysis as a new Academic in Residence. He brings significant expertise in the identification and characterisation of novel therapeutic targets using a wide range of applied...

For the past four years, the Milner Therapeutics Institute has been incubating in the Gurdon Institute – home to the research lab of our Director Tony Kouzarides. This provided essential support as the Milner team was growing and developing key strategic partnerships,...

This month, we celebrated the launch of the Milner Therapeutics Institute in the Jeffrey Cheah Biomedical Centre. Key academics and consortium members gathered in our brand new auditorium. Our Director, Tony Kouzarides, gave the vision of the Milner Therapeutics...

We are excited to be celebrating the launch of the AstraZeneca-Cancer Research UK Functional Genomics Centre today. Based in the Milner Therapeutics Institute, this collaborative team will be utilising CRISPR technologies to better understand cancer biology, creating...